Follow-Up of Children Born to Mothers in Folic Acid Clinical Trial (FACT 4 Child): A Prospective Cohort Study Based on a Double-Blinded Randomised Controlled Trial
- PMID: 40859816
- DOI: 10.1111/1471-0528.18341
Follow-Up of Children Born to Mothers in Folic Acid Clinical Trial (FACT 4 Child): A Prospective Cohort Study Based on a Double-Blinded Randomised Controlled Trial
Abstract
Objective: To assess the impact of high-dose folic acid supplementation (4.0-5.1 mg), started between 8+0 and 16+6 weeks of gestation and continued until delivery, on social impairments associated with Autism Spectrum Disorders, deficiencies in executive function, and emotional and behavioural problems in children.
Design: FACT 4 Child is a follow-up of mothers and their children born during the Folic Acid Clinical Trial (FACT), an international multi-centre double-blinded randomised trial to assess the effect of high-dose folic acid supplementation on preventing preeclampsia in women with increased risk.
Setting: Multi-centre international follow-up study.
Population: Mothers and their children enrolled in FACT, among them 664 completed the follow-up.
Methods: Mothers reported on social and executive function and emotional and behavioural problems in their children aged 4-9 years using standardised, validated questionnaires.
Main outcome: The proportion of children with at least one score > 1.5 SD above expected mean.
Results: Among 319 children in the intervention group, 43 (13.5%) had a score in the elevated range, compared with 51/345 (14.8%) in the placebo group (RR = 0.91; 95% CI: 0.63 to 1.33; p = 0.63).
Conclusion: In children born to women at risk for preeclampsia, rates of neurodevelopmental outcomes were not different between high-dose folic acid and control groups in this study. Our finding suggests that a high dose of folic acid supplementation may not be needed in pregnant women with increased risk. A larger-scale study is needed to determine neurodevelopmental outcomes associated with different dosages and timing of folic acid supplementation during pregnancy.
Keywords: autism spectrum disorders; folic acid; neurodevelopment; pregnancy; social impairments.
© 2025 John Wiley & Sons Ltd.
References
-
- S. W. Wen, X. K. Chen, M. Rodger, et al., “Folic Acid Supplementation in Early Second Trimester and the Risk of Preeclampsia,” American Journal of Obstetrics and Gynecology 198, no. 1 (2008): 45, https://doi.org/10.1016/j.ajog.2007.06.067.
-
- S. W. Wen, Y. Guo, M. Rodger, et al., “Folic Acid Supplementation in Pregnancy and the Risk of Pre‐Eclampsia‐A Cohort Study,” PLoS One 11, no. 2 (2016): e0149818, https://doi.org/10.1371/journal.pone.0149818.
-
- S. W. Wen, R. R. White, N. Rybak, et al., “Effect of High Dose Folic Acid Supplementation in Pregnancy on Pre‐Eclampsia (FACT): Double Blind, Phase III, Randomised Controlled, International, Multicentre Trial,” British Medical Journal 362 (2018): k3478, https://doi.org/10.1136/bmj.k3478.
-
- M. J. Maenner, Z. Warren, A. R. Williams, et al., “Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2020,” MMWR Surveillance Summaries 72, no. 2 (2023): 1–14, https://doi.org/10.15585/mmwr.ss7202a1.
-
- A. V. S. Buescher, Z. Cidav, M. Knapp, and D. S. Mandell, “Costs of Autism Spectrum Disorders in the United Kingdom and the United States,” JAMA Pediatrics 168, no. 8 (2014): 721–728, https://doi.org/10.1001/jamapediatrics.2014.210.
Grants and funding
LinkOut - more resources
Full Text Sources